|Bid||0.00 x 800|
|Ask||0.00 x 1100|
|Day's Range||29.08 - 29.58|
|52 Week Range||24.43 - 40.67|
|Beta (3Y Monthly)||1.15|
|PE Ratio (TTM)||25.43|
|Earnings Date||Feb 20, 2020 - Feb 24, 2020|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||38.00|
We are still in an overall bull market and many stocks that smart money investors were piling into surged through the end of November. Among them, Facebook and Microsoft ranked among the top 3 picks and these stocks gained 54% and 51% respectively. Hedge funds' top 3 stock picks returned 41.7% this year and beat […]
HMS Holdings (HMSY) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Many investors are still learning about the various metrics that can be useful when analysing a stock. This article is...
Moody's Investors Service ("Moody's") downgraded Intrado Corporation's ("Intrado") Corporate Family Rating (CFR) to B3, from B2, Probability of Default Rating to B3-PD, from B2-PD, senior secured ratings to B2, from B1, and the ratings for senior unsecured notes to Caa2, from Caa1. The ratings outlook is stable.
The Irving-based company, which provides technology and analytics for the health care industry, is making another acquisition – and this one’s much bigger than the last purchase it made almost two months ago.
Intrado’s Claims Recovery business, known in the market as Accent, is a leading provider of healthcare payment integrity solutions to insurance companies and large self-funded organizations. “After further strategic review, we have decided to sell the Accent business to allow greater focus on our core cloud businesses,” said John Shlonsky, President and Chief Executive Officer of Intrado.
IRVING, Texas, Nov. 21, 2019 -- HMS Holdings Corp. (Nasdaq: HMSY) today announced it has signed a definitive agreement to acquire Accent, a payment accuracy and cost.
HMS Holdings (HMSY) delivered earnings and revenue surprises of 11.11% and -11.27%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?
3Q'19 Total Revenue of $146.8 Million, (-4.8%) vs. 3Q'18; YTD'19 Total Revenue +4.6% vs. YTD'18 3Q'19 Net Income of $21.1 Million vs. $18.6 Million in 3Q'18; YTD'19 Net Income.
HMS Holdings (HMSY) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Based on the fact that hedge funds have collectively under-performed the market for several years, it would be easy to assume that their stock picks simply aren't very good. However, our research shows this not to be the case. In fact, when it comes to their very top picks collectively, they show a strong ability […]
Today, we'll introduce the concept of the P/E ratio for those who are learning about investing. To keep it practical...
IRVING, Texas, Oct. 08, 2019 -- HMS Holdings Corp. (Nasdaq: HMSY) today announced it will report financial and operating results for the third quarter ended September 30, 2019.
HMS Holdings Corp. (HMSY), a leading U.S.-based provider of healthcare technology, analytics and engagement solutions, today announced that HMS, through a subsidiary, will make a strategic investment of $7.5 million (US) in ordinary shares of MedAdvisor Limited (ASX:MDR), Australia’s leading digital medication management company. HMS intends to fund the investment with cash on hand. Upon completion of the transaction, HMS will hold an approximate 13% ownership stake in MedAdvisor.
If you're interested in HMS Holdings Corp. (NASDAQ:HMSY), then you might want to consider its beta (a measure of share...
Whenever the S&P 500 declines at least 1% in the first trading day in October, the index gains an average 3.75% for the rest of October.